spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 12 Jul 2011
Celsion Announces Management and Board Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2011
POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2011
Ascletis Names Allan Baxter, PhD, Former GlaxoSmithKline Global Head of Medicines Development, as Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jul 2011
Robert Jones Appointed President & CEO and to the Board of Directors of Acura Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2011
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada(TM)*) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2011
Valeant Pharmaceuticals Agrees to Acquire Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 8 Jul 2011
Acura Pharmaceuticals, Inc. Announces the Retirement of William A. Sumner From Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2011
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2011
Coronado Biosciences Closes $25.8M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2011
GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jul 2011
Steven H. Collis Succeeds R. David Yost as CEO of AmerisourceBergen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
FDA Accepts Submission of New Drug Application for CORLUX for Cushing's Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 29 Jun 2011
Pulmatrix Promotes Robert Clarke, PhD, to Chief Scientific Officer and Vice President of Research and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Jun 2011
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jun 2011
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2011
Nimbus Discovery Secures $24 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Jun 2011
Novavax Appoints Dr. Timothy Hahn Senior Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2011
Alternative Pain Therapy for Breast, Prostate and Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2011
SciFluor Life Sciences Appoints Life Sciences Executive Arthur Hiller as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2011
OncoSec Closes $3.0 Million Private Placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Jun 2011
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jun 2011
Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 23 Jun 2011
Jules A. Müsing Joins iBio’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2011
Agennix Hires Jill Porter as Senior Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2011
Geoffrey McDonough appointed President and CEO of Sobi
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 20 Jun 2011
Endo Pharmaceuticals Successfully Completes Acquisition of American Medical Systems for $2.9 Billion
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Jun 2011
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 20 Jun 2011
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2011
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2011
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Biopharmaceuticals Generics
 HSMN NewsFeed - 17 Jun 2011
Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2011
NovaBay Regains Worldwide Rights to Its Aganocide Compounds From Alcon
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jun 2011
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jun 2011
Easton Pharmaceuticals Announces The Appointment of John Easton as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Tetragenetics Announces New CEO and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Genesis Biopharma Names Martin Schroeder to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jun 2011
Cytochroma Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Spectrum Pharmaceuticals Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga (ezogabine)
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jun 2011
Revance Announces $45 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jun 2011
NovaDel Announces Changes in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2011
FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jun 2011
TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2011
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2011
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex(R) for GliaSite(R) Brain Cancer Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 7 Jun 2011
Biogen Idec Receives Approval in the European Union for AVONEX(R) PEN(TM)
Biopharmaceuticals Drug Delivery Neurology Regulatory
 HSMN NewsFeed - 6 Jun 2011
AVI BioPharma Names Ed Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2011
Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jun 2011
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jun 2011
Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2011
Tarceva Nearly Doubled the Time People With a Genetically Distinct Type of Lung Cancer Lived Without Their Disease Getting Worse
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2011
Healthpoint Biotherapeutics Acquires Regranex(R) Gel
Biopharmaceuticals Wound Care Acquisitions
 HSMN NewsFeed - 2 Jun 2011
Marshall Edwards Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jun 2011
Galectin Therapeutics Announces the Appointment of Kevin Freeman and John Mauldin to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2011
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Jun 2011
Lannett Announces Changes to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 1 Jun 2011
Esperance Pharmaceuticals Completes $7.5 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 May 2011
Pharmascience Acquires Aegera Therapeutics Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2011
Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2011
Genetic Technologies Files New Patent Infringement Suit in USA
Biopharmaceuticals Diagnostics Oncology Litigation
 HSMN NewsFeed - 26 May 2011
Lilly Comments on Court Ruling in Amylin Litigation
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 25 May 2011
NanoBio(R) Appoints Peter Ulrich to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2011
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2011
Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 May 2011
Watson Acquires Specifar Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 25 May 2011
FDA Approves Trial of Pathway Therapeutics, Inc. Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 May 2011
Cerecor, Incorporated Initiates Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 May 2011
Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2011
Par Pharmaceutical to Acquire Edict Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2011
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 May 2011
ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 20 May 2011
EMD Serono President and CEO Fereydoun Firouz Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 May 2011
European Medicines Agency’s Committee for Medicinal Products for Human Use Issues Positive Opinion on Marketing Authorisation Application for FAMPYRA
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 20 May 2011
GlaxoSmithKline and Human Genome Sciences Receive Positive Opinion in Europe from the CHMP for BENLYSTA(R) (Belimumab)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 May 2011
Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2011
Nycomed's US Dermatology Business to Become an Independent Entity Following Nycomed's Acquisition by Takeda
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 18 May 2011
Regulus Therapeutics Expands Executive Team with Recent Appointments
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!